These 3 Dividend Stocks Have Made Investors Rich. They Can Do It Again.

Hershey is seeing margin recovery as cocoa prices fall 74% from the December 2024 peak, with Q1 2026 gross margin expanding to 39.4% from 33.7% and EPS beating consensus by 14.9%. General Mills offers a roughly 7% dividend yield amid weak organic sales, while Kimberly-Clark’s $48.7 billion Kenvue acquisition could create a larger health and personal-care platform if integration succeeds. The article is broadly constructive on dividend stocks, but each name still carries execution or demand risk.

Analysis

The cleanest read-through is that the sector’s earnings power is being re-rated by input-cost deflation, but the beneficiaries are uneven. HSY is the highest-beta expression of the cocoa unwind because its margin delta is still front-end loaded; the market is likely underestimating how quickly operating leverage can re-accelerate once lagged costs roll through, but it is also overestimating how quickly volume recovers if consumers remain trading down. That creates a favorable months-ahead setup, not a straight-line one.

GIS is a different animal: the 7% yield is less about growth and more about pricing a balance-sheet-safe “wait for normalization” trade. The structural issue is that legacy center-store packaged foods are still losing shelf relevance, so the real upside comes from cost reset and pet-food mix, not a broad demand rebound. If management can stabilize margins without another round of volume attrition, the stock can mean-revert; if not, the yield becomes a value trap because the market will keep questioning real earnings power.

KMB’s Kenvue transaction is the most interesting second-order story because it converts a defensive dividend name into a branded health-and-personal-care platform with more pricing power and category diversification. The key risk is not strategic logic but execution drag: integration, leverage, and synergy timing could suppress multiple expansion for several quarters even if the long-term thesis is right. In other words, the stock likely trades on bridge credibility over the next 6–12 months rather than the eventual portfolio quality.

The contrarian angle is that consensus is treating these as three separate dividend stories, when they are really one macro trade on disinflation, staples de-rating, and capital-return durability. The market may be too slow to price how much cocoa normalization improves HSY versus how little growth is embedded in GIS, while KMB deserves a premium only if the market believes the deal can close and delever without a dividend miss. This favors selective longs over broad staples exposure.

Key Decisions for Investors

• Long HSY into the next 1-2 quarters as a margin-recovery trade; best risk/reward if cocoa costs continue to lag lower. Use a tighter stop if management signals volume deterioration is offsetting gross margin expansion.
• Pair trade: long HSY / short GIS for 3-6 months. Thesis: HSY has visible earnings inflection from commodity deflation, while GIS is still dependent on stabilization and investor patience for a full re-rate.
• Hold or initiate GIS only as an income carry position, not a growth proxy; target 12-month total return is mostly yield-driven. Avoid chasing unless the stock trades materially below 8x forward earnings with no further volume deterioration.
• Watch KMB on any post-close weakness and consider starting a starter long on completion confirmation, not headlines. The trade works only if integration risk is priced in faster than synergy realization over 6-18 months.
• Relative-value preference: overweight HSY and KMB versus broad staples ETFs; underweight “safe yield” names without a specific catalyst, since the market is likely to pay up only for dividend sustainability plus visible earnings inflection.